Lessons from Anaplasma phagocytophilum: Chromatin remodeling by bacterial effectors

Infectious Disorders - Drug Targets

Volumn 12, Issue 5, 2012, Pages 380-387

  Rennoll Bankert, Kristen E ^a   Dumler, J Stephen ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anaplasma phagocytophilum; And NADPH oxidase; AnkA; CYBB; Epigenetics; Histone modifications

Indexed keywords

ANKA PROTEIN; BACTERIAL PROTEIN; BUTYRIC ACID; HISTONE DEACETYLASE 1; HISTONE H3; INTERFERON REGULATORY FACTOR 1; LISTERIOLYSIN O; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRICHOSTATIN A; UNCLASSIFIED DRUG;

AT RICH SEQUENCE; BACTERIAL SURVIVAL; CHLAMYDIA TRACHOMATIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENETICS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; HUMAN GRANULOCYTIC ANAPLASMOSIS; IMMUNE RESPONSE; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; MATRIX ATTACHMENT REGION; NEUTROPHIL; NONHUMAN; PROMOTER REGION; RESPIRATORY BURST; REVIEW; SHIGELLA FLEXNERI;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; EHRLICHIOSIS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; TRANSCRIPTION, GENETIC;

EID: 84872225803     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/187152612804142242     Document Type: Review

References (70)

1. Bhavsar, A. P.; Guttman, J. A.; Finlay, B. B. Manipulation of hostcell pathways by bacterial pathogens. Nature, 2007, 449, 827-834.
2. Bryant, P. A.; Venter, D.; Robins-Browne, R.; Curtis, N. Chips with everything: DNA microarrays in infectious diseases. Lancet Infect. Dis., 2004, 4, 100-111.
3. Thomson, S.; Clayton, A. L.; Hazzalin, C. A.; Rose, S.; Barratt, M. J.; Mahadevan, L. C. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J., 1999, 18, 4779-4793.
4. Clayton, A. L.; Mahadevan, L. C. MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett., 2003, 546, 51-58.
5. Mahadevan, L. C.; Willis, A. C.; Barratt, M. J. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell, 1991, 65, 775-783.
6. Saccani, S.; Pantano, S.; Natoli, G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat. Immunol., 2002, 3, 69-75.
7. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol., 2004, 4, 499-511.
8. Dumler, J. S.; Barbet, A. F.; Bekker, C. P.; Dasch, G. A.; Palmer, G. H.; Ray, S. C.; Rikihisa, Y.; Rurangirwa, F. R. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective syno nyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol., 2001, 51, 2145-2165.
9. Lin, M.; Rikihisa, Y. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect. Immun., 2003, 71, 5324-5331.
10. Herron, M. J.; Ericson, M. E.; Kurtti, T. J.; Munderloh, U. G. The interactions of Anaplasma phagocytophilum, endothelial cells, and human neutrophils. Ann. N. Y. Acad. Sci., 2005, 1063, 374-382.
11. Klein, M. B.; Miller, J. S.; Nelson, C. M.; Goodman, J. L. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J. Infect. Dis., 1997, 176, 1405-1409.
12. Nathan, C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol., 2006, 6, 173-182.
13. Laskay, T.; van Zandbergen, G.; Solbach, W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology, 2008, 213, 183-191.
14. Brinkmann, V.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D. S.; Weinrauch, Y.; Zychlinsky, A. Neutrophil extracellular traps kill bacteria. Science, 2004, 303, 1532-1535.
15. Ge, Y.; Yoshiie, K.; Kuribayashi, F.; Lin, M.; Rikihisa, Y. Anaplasma phagocytophilum inhibits human neutrophil apoptosis via upregulation of bfl-1, maintenance of mitochondrial membrane potential and prevention of caspase 3 activation. Cell. Microbiol., 2005, 7, 29-38.
16. Yoshiie, K.; Kim, H. Y.; Mott, J.; Rikihisa, Y. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect. Immun., 2000, 68, 1125-1133.
17. Choi, K. S.; Park, J. T.; Dumler, J. S. Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway. Infect. Immun., 2005, 73, 8209-8218.
18. Klein, M. B.; Hu, S.; Chao, C. C.; Goodman, J. L. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J. Infect. Dis., 2000, 182, 200-205.
19. Scorpio, D. G.; Akkoyunlu, M.; Fikrig, E.; Dumler, J. S. CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Clin. Diagn. Lab. Immunol., 2004, 11, 963-968.
20. Choi, K. S.; Garyu, J.; Park, J.; Dumler, J. S. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect. Immun., 2003, 71, 4586-4594.
21. Choi, K. S.; Grab, D. J.; Dumler, J. S. Anaplasma phagocytophilum infection induces protracted neutrophil degranulation. Infect. Immun., 2004, 72, 3680-3683.
22. de la Fuente, J.; Ayoubi, P.; Blouin, E. F.; Almazan, C.; Naranjo, V.; Kocan, K. M. Gene expression profiling of human promyelocytic cells in response to infection with Anaplasma phagocytophilum. Cell. Microbiol., 2005, 7, 549-559.
23. Pedra, J. H.; Sukumaran, B.; Carlyon, J. A.; Berliner, N.; Fikrig, E. Modulation of NB4 promyelocytic leukemic cell machinery by Anaplasma phagocytophilum. Genomics, 2005, 86, 365-377.
24. Lee, H. C.; Kioi, M.; Han, J.; Puri, R. K.; Goodman, J. L. Anaplasma phagocytophilum-induced gene expression in both human neutrophils and HL-60 cells. Genomics, 2008, 92, 144-151.
25. Carlyon, J. A.; Chan, W. T.; Galan, J.; Roos, D.; Fikrig, E. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J. Immunol., 2002, 169, 7009-7018.
26. Carlyon, J. A.; Abdel-Latif, D.; Pypaert, M.; Lacy, P.; Fikrig, E. Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect. Immun., 2004, 72, 4772-4783.
27. Newburger, P. E.; Ezekowitz, R. A.; Whitney, C.; Wright, J.; Orkin, S. H. Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma. Proc. Natl. Acad. Sci. USA, 1988, 85, 5215-5219.
28. Skalnik, D. G.; Dorfman, D. M.; Perkins, A. S.; Jenkins, N. A.; Copeland, N. G.; Orkin, S. H. Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc. Natl. Acad. Sci. USA, 1991, 88, 8505-8509.
29. Eklund, E. A.; Kakar, R. Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequencebinding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression. J. Immunol., 1999, 163, 6095-6105.
30. Luo, W.; Skalnik, D. G. Interferon regulatory factor-2 directs transcription from the gp91phox promoter. J. Biol. Chem., 1996, 271, 23445-23451.
31. Jacobsen, B. M.; Skalnik, D. G. YY1 binds five cis-elements and trans-activates the myeloid cell-restricted gp91(phox) promoter. J. Biol. Chem., 1999, 274, 29984-29993.
32. Bei, L.; Lu, Y.; Eklund, E. A. HOXA9 activates transcription of the gene encoding gp91Phox during myeloid differentiation. J. Biol. Chem., 2005, 280, 12359-12370.
33. Skalnik, D. G.; Strauss, E. C.; Orkin, S. H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem., 1991, 266, 16736-16744.
34. Lievens, P. M.; Donady, J. J.; Tufarelli, C.; Neufeld, E. J. Repressor activity of CCAAT displacement protein in HL-60 myeloid leukemia cells. J. Biol. Chem., 1995, 270, 12745-12750.
35. Luo, W.; Skalnik, D. G. CCAAT displacement protein competes with multiple transcriptional activators for binding to four sites in the proximal gp91phox promoter. J. Biol. Chem., 1996, 271, 18203-18210.
36. Hawkins, S. M.; Kohwi-Shigematsu, T.; Skalnik, D. G. The matrix attachment region-binding protein SATB1 interacts with multiple elements within the gp91phox promoter and is down-regulated during myeloid differentiation. J. Biol. Chem., 2001, 276, 44472-44480.
37. Fujii, Y.; Kumatori, A.; Nakamura, M. SATB1 makes a complex with p300 and represses gp91(phox) promoter activity. Microbiol. Immunol., 2003, 47, 803-811.
38. Eklund, E. A.; Goldenberg, I.; Lu, Y.; Andrejic, J.; Kakar, R. SHP1 protein-tyrosine phosphatase regulates HoxA10 DNA binding and transcriptional repression activity in undifferentiated myeloid cells. J. Biol. Chem., 2002, 277, 36878-36888.
39. Thomas, V.; Samanta, S.; Wu, C.; Berliner, N.; Fikrig, E. Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein. Infect. Immun., 2005, 73, 208-218.
40. Thomas, V.; Samanta, S.; Fikrig, E. Anaplasma phagocytophilum increases cathepsin L activity, thereby globally influencing neutrophil function. Infect. Immun., 2008, 76, 4905-4912.
41. Garcia-Garcia, J. C.; Rennoll-Bankert, K. E.; Pelly, S.; Milstone, A. M.; Dumler, J. S. Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect. Immun., 2009, 77, 2385-2391.
42. Caturegli, P.; Asanovich, K. M.; Walls, J. J.; Bakken, J. S.; Madigan, J. E.; Popov, V. L.; Dumler, J. S. ankA: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect. Immun., 2000, 68, 5277-5283.
43. Bork, P. Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins, 1993, 17, 363-374.
44. Bustin, M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol., 1999, 19, 5237-5246.
45. Lin, M.; den Dulk-Ras, A.; Hooykaas, P. J.; Rikihisa, Y. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell. Microbiol., 2007, 9, 2644-2657.
46. Park, J.; Kim, K. J.; Choi, K. S.; Grab, D. J.; Dumler, J. S. Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell. Microbiol., 2004, 6, 743-751.
47. Bode, J.; Kohwi, Y.; Dickinson, L.; Joh, T.; Klehr, D.; Mielke, C.; Kohwi-Shigematsu, T. Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science, 1992, 255, 195-197.
48. Kohwi-Shigematsu, T.; Kohwi, Y. Torsional stress stabilizes extended base unpairing in suppressor sites flanking immunoglobulin heavy chain enhancer. Biochemistry, 1990, 29, 9551-9560.
49. Garcia-Garcia, J. C.; Barat, N. C.; Trembley, S. J.; Dumler, J. S. Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog., 2009, 5, e1000488.
50. Zhu, B.; Nethery, K. A.; Kuriakose, J. A.; Wakeel, A.; Zhang, X.; McBride, J. W. Nuclear translocated Ehrlichia chaffeensis ankyrin protein interacts with a specific adenine-rich motif of host promoter and intronic Alu elements. Infect. Immun., 2009, 77, 4243-4255.
51. Jung, H. C.; Eckmann, L.; Yang, S. K.; Panja, A.; Fierer, J.; Morzycka-Wroblewska, E.; Kagnoff, M. F. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest., 1995, 95, 55-65.
52. Zurawski, D. V.; Mitsuhata, C.; Mumy, K. L.; McCormick, B. A.; Maurelli, A. T. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infect. Immun., 2006, 74, 5964-5976.
53. Arbibe, L.; Kim, D. W.; Batsche, E.; Pedron, T.; Mateescu, B.; Muchardt, C.; Parsot, C.; Sansonetti, P. J. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol., 2007, 8, 47-56.
54. Li, H.; Xu, H.; Zhou, Y.; Zhang, J.; Long, C.; Li, S.; Chen, S.; Zhou, J. M.; Shao, F. The phosphothreonine lyase activity of a bacterial type III effector family. Science, 2007, 315, 1000-1003.
55. O'Connell, R. M.; Saha, S. K.; Vaidya, S. A.; Bruhn, K. W.; Miranda, G. A.; Zarnegar, B.; Perry, A. K.; Nguyen, B. O.; Lane, T. F.; Taniguchi, T.; Miller, J. F.; Cheng, G. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med., 2004, 200, 437-445.
56. McCaffrey, R. L.; Fawcett, P.; O'Riordan, M.; Lee, K. D.; Havell, E. A.; Brown, P. O.; Portnoy, D. A. A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc. Natl. Acad. Sci. USA, 2004, 101, 11386-11391.
57. Lecuit, M.; Sonnenburg, J. L.; Cossart, P.; Gordon, J. I. Functional genomic studies of the intestinal response to a foodborne enteropathogen in a humanized gnotobiotic mouse model. J. Biol. Chem., 2007, 282, 15065-15072.
58. Hamon, M. A.; Batsche, E.; Regnault, B.; Tham, T. N.; Seveau, S.; Muchardt, C.; Cossart, P. Histone modifications induced by a family of bacterial toxins. Proc. Natl. Acad. Sci. USA, 2007, 104, 13467-13472.
59. Lebreton, A.; Lakisic, G.; Job, V.; Fritsch, L.; Tham, T. N.; Camejo, A.; Mattei, P. J.; Regnault, B.; Nahori, M. A.; Cabanes, D.; Gautreau, A.; Ait-Si-Ali, S.; Dessen, A.; Cossart, P.; Bierne, H. A bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon response. Science, 2011, 331, 1319-1321.
60. Bischofberger, M.; Gonzalez, M. R.; van der Goot, F. G. Membrane injury by pore-forming proteins. Curr. Opin. Cell Biol., 2009, 21, 589-595.
61. Palmer, M. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon, 2001, 39, 1681-1689.
62. Tang, P.; Rosenshine, I.; Cossart, P.; Finlay, B. B. Listeriolysin O activates mitogen-activated protein kinase in eucaryotic cells. Infect. Immun., 1996, 64, 2359-2361.
63. Repp, H.; Pamukci, Z.; Koschinski, A.; Domann, E.; Darji, A.; Birringer, J.; Brockmeier, D.; Chakraborty, T.; Dreyer, F. Listeriolysin of Listeria monocytogenes forms Ca2+-permeable pores leading to intracellular Ca2+ oscillations. Cell. Microbiol., 2002, 4, 483-491.
64. Dramsi, S.; Cossart, P. Listeriolysin O-mediated calcium influx potentiates entry of Listeria monocytogenes into the human Hep-2 epithelial cell line. Infect. Immun., 2003, 71, 3614-3618.
65. Hamon, M. A.; Cossart, P. K+ efflux is required for histone H3 dephosphorylation by Listeria monocytogenes listeriolysin O and other pore-forming toxins. Infect. Immun., 2011, 79, 2839-2846.
66. Pamer, E. G. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol., 2004, 4, 812-823.
67. Gantt, S. L.; Joseph, C. G.; Fierke, C. A. Activation and inhibition of histone deacetylase 8 by monovalent cations. J. Biol. Chem., 2010, 285, 6036-6043.
68. Bierne, H.; Tham, T. N.; Batsche, E.; Dumay, A.; Leguillou, M.; Kerneis-Golsteyn, S.; Regnault, B.; Seeler, J. S.; Muchardt, C.; Feunteun, J.; Cossart, P. Human BAHD1 promotes heterochromatic gene silencing. Proc. Natl. Acad. Sci. USA, 2009, 106, 13826-13831.
69. Pennini, M. E.; Perrinet, S.; Dautry-Varsat, A.; Subtil, A. Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatis. PLoS Pathog. 2010, 6, e1000995.
70. Mombelli, M.; Lugrin, J.; Rubino, I.; Chanson, A. L.; Giddey, M.; Calandra, T.; Roger, T. Histone deacetylase inhibitors impair antibacterial defenses of macrophages. J. Infect. Dis., 2011, 204, 1367-1374.